The intracellular lipolytic factor, a/b-hydrolase domain-containing 5 (ABHD5), has been identified as a novel tumor suppressor in CRC, and its loss significantly promotes CRC tumorigenesis and metastasis (Ou et al., 2014). The gene discussed is ABHD5; the disease is colorectal carcinoma.